Cytochrome P450 enzymes in the brain: Emerging evidence of biological significance

Trends in Pharmacological Sciences

Volumn 32, Issue 12, 2011, Pages 708-714

  Ferguson, Charmaine S ^a   Tyndale, Rachel F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOZAPINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J; CYTOCHROME P450 2U; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 4A; CYTOCHROME P450 INHIBITOR; NICOTINE; OXCARBAZEPINE; PHENYTOIN; UNCLASSIFIED DRUG;

ALCOHOLISM; BEHAVIOR DISORDER; BRAIN; BRAIN FUNCTION; COGNITIVE DEFECT; ELECTROENCEPHALOGRAM; ENZYME ACTIVITY; ENZYME METABOLISM; EPILEPSY; HUMAN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SMOKING;

ANIMALS; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HUMANS; NERVE TISSUE PROTEINS; NEURONS;

EID: 81755174301     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2011.08.005     Document Type: Review

References (60)

1. E. Hedlund Cytochrome P450 in the brain; a review Curr. Drug Metab. 2 2001 245 263 (Pubitemid 32785272)
2. R.P. Meyer Expression and function of cytochrome P450 in brain drug metabolism Curr. Drug Metab. 8 2007 297 306 (Pubitemid 46780059)
3. S. Miksys Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain Neuropharmacology 45 2003 122 132 (Pubitemid 36700458)
4. L.A. Howard Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics Br. J. Pharmacol. 138 2003 1376 1386 (Pubitemid 36543136)
5. S. Miksys Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics J. Neurochem. 82 2002 1376 1387
6. M.R. Britto, and P.J. Wedlund Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes Drug Metab. Dispos. 20 1992 446 450
7. S. Miksys Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment Biochem. Pharmacol. 59 2000 1501 1511 (Pubitemid 30229882)
8. E.R. Simpson Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr. Rev. 15 1994 342 355 (Pubitemid 24180792)
9. C.E. Roselli, and J.A. Resko Sex differences in androgen-regulated expression of cytochrome P450 aromatase in the rat brain J. Steroid. Biochem. Mol. Biol. 61 1997 365 374 (Pubitemid 27459891)
10. B. Stoffel-Wagner Expression of CYP19 (aromatase) mRNA in different areas of the human brain J. Steroid. Biochem. Mol. Biol. 70 1999 237 241 (Pubitemid 29528435)
11. S. Miksys, and R.F. Tyndale Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition Neuropsychopharmacology 34 2009 634 640
12. B. Schilter Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers J. Pharmacol. Exp. Ther. 294 2000 916 922 (Pubitemid 30666841)
13. P. Huang Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary Toxicol. Appl. Pharmacol. 169 2000 159 167
14. M.J. Sanchez-Catalan Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat Alcohol. Alcohol. 43 2008 401 407 (Pubitemid 351965908)
15. E. Hedlund Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene Mol. Pharmacol. 50 1996 342 350 (Pubitemid 26265139)
16. A. Mann Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment Neuropharmacology 55 2008 1147 1155
17. S. Yadav Expression of constitutive and inducible cytochrome P450 2E1 in rat brain Mol. Cell Biochem. 286 2006 171 180
18. B.J. Roberts Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less Biochem. Biophys. Res. Commun. 205 1994 1064 1071
19. M. Joshi, and R.F. Tyndale Induction and recovery time course of rat brain CYP2E1 after nicotine treatment Drug Metab. Dispos. 34 2006 647 652
20. D. Wu Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture Mol. Cell Biochem. 173 1997 103 111 (Pubitemid 27389084)
21. E. Bromek Cytochrome P450 mediates dopamine formation in the brain in vivo J. Neurochem. 118 2011 806 815
22. A.M. Yu Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6 Pharmacogenetics 13 2003 173 181
23. M. Ingelman-Sundberg Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future Trends Pharmacol. Sci. 25 2004 193 200 (Pubitemid 38519910)
24. L.E.M. Penas Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers Pharmacogenomics 10 2009 1111 1120
25. J. Kirchheiner CYP2D6 in the brain: genotype effects on resting brain perfusion Mol. Psychiatry 16, 237 2011 333 341
26. G. Ishii CYP2C19 polymorphism affects personality traits of Japanese females Neurosci. Lett. 411 2007 77 80 (Pubitemid 44751944)
27. H. Yamazaki, and T. Shimada Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes Arch. Biochem. Biophys 346 1997 161 169 (Pubitemid 27415307)
28. R. Michels, and P.M. Marzuk Progress in psychiatry (1) N. Engl. J. Med. 329 1993 552 560
29. J.Y. Khokhar, and R.F. Tyndale Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects Neuropsychopharmacology 36 2010 692 700
30. J. Mercapide Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma Int. J. Cancer 126 2010 1206 1215
31. + BMC Cancer 10 2010 487
32. N. Killer Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy Epilepsia 50 2009 1875 1890
33. R.W. Wang Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis Drug Metab. Dispos. 25 1997 502 507 (Pubitemid 27209375)
34. A.J. Lee Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms Endocrinology 144 2003 3382 3398 (Pubitemid 36904414)
35. B.S. McEwen How do sex and stress hormones affect nerve cells? Ann. N.Y. Acad. Sci. 743 1994 1 16
36. C. Leranth Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats J. Neurosci. 23 2003 1588 1592 (Pubitemid 36314713)
37. E. Munetsuna Retinoic acid stimulates 17beta-estradiol and testosterone synthesis in rat hippocampal slice cultures Endocrinology 150 2009 4260 4269
38. A. Verrotti Hormonal and reproductive disturbances in epileptic male patients: Emerging issues Reprod. Toxicol. 3 2011 519 527
39. S. Beyenburg Anxiety in patients with epilepsy: systematic review and suggestions for clinical management Epilepsy Behav. 7 2005 161 171 (Pubitemid 41149518)
40. J.I. Isojarvi Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy CNS Drugs 19 2005 207 223 (Pubitemid 40460661)
41. R.P. Meyer Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus J. Neurochem. 96 2006 460 472
42. A.B. Rifkind CYP1A in TCDD toxicity and in physiology - with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates Drug Metab. Rev. 38 2006 291 335 (Pubitemid 43739012)
43. I.P. Stolerman, and M.J. Jarvis The scientific case that nicotine is addictive Psychopharmacology (Berl.) 117 1995 2 10
44. H. Yamazaki Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes Arch. Toxicol. 73 1999 65 70 (Pubitemid 29226163)
45. M.T. Bardo Nornicotine is self-administered intravenously by rats Psychopharmacology (Berl.) 146 1999 290 296 (Pubitemid 29480240)
46. T.A. Green Nornicotine pretreatment decreases intravenous nicotine self-administration in rats Psychopharmacology (Berl.) 152 2000 289 294
47. A.M. Lee CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial Biol. Psychiatry 62 2007 635 641 (Pubitemid 47314367)
48. C. Lerman Pharmacogenetic investigation of smoking cessation treatment Pharmacogenetics 12 2002 627 634 (Pubitemid 36005672)
49. A.M. Lee CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy Cancer Epidemiol. Biomarkers Prev. 16 2007 1312 1314 (Pubitemid 46984979)
50. S.J. McCann The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis J. Neurol. Sci. 153 1997 50 53 (Pubitemid 28010066)
51. A. Elbaz CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease Ann. Neurol. 55 2004 430 434 (Pubitemid 38269597)
52. Mann, A. et al. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiol. Aging, in press.
53. A. Mann, and R.F. Tyndale Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells Eur. J. Neurosci. 31 2010 1185 1193
54. I. Siegle Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain Pharmacogenetics 11 2001 237 245 (Pubitemid 32319873)
55. G. Alves Cigarette smoking in Parkinson's disease: influence on disease progression Mov. Disord. 19 2004 1087 1092 (Pubitemid 39302846)
56. R.A. Popat Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease Eur. J. Neurol. 18 2011 756 765
57. M.C. Morale Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease? Brain Res. Rev. 57 2008 431 443
58. A.N. Garcia Cyp46 polymorphisms in Alzheimer's disease: a review J. Mol. Neurosci. 39 2009 342 345
59. H.T. Butler Association of the aromatase gene with Alzheimer's disease in women Neurosci. Lett. 468 2010 202 206
60. J.L. Conroy Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling Nat. Neurosci. 13 2010 284 286